Newborn Stem Cell Banking

Umbilical Cord Mesenchymal Stem Cells - Repair Masters


Mesenchymal stem cells are an important member of the stem cell family. Under specific induction conditions, they can differentiate into various specialized cells, including adipocytes, osteocytes, chondrocytes, myocytes, and tenocytes. Stem cells retain their multidirectional differentiation potential even after repeated subculturing and cryopreservation, making them excellent candidates for tissue and organ regeneration.






Clinical Research Scope:


Autoimmune diseases

● Rheumatoid arthritis, graft-versus-host disease, etc.


Cardiovascular and cerebrovascular diseases

● Myocardial infarction, cerebral infarction, etc.


Neurological diseases

● Spinal cord injury, Parkinson's disease, etc.


Endocrine disorders

● Type 1 diabetes, type 2 diabetes, and associated complications


Hematologic diseases

● Promotes hematopoietic function recovery and mitigates graft-versus-host disease, etc.


Degenerative diseases

● Osteoarthritis, Alzheimer's disease, etc.


Gastrointestinal diseases

● Liver cirrhosis, renal insufficiency, etc.


Orthopedic diseases

● Degenerative arthritis, femoral head necrosis, osteoporosis, bone nonunion, etc.


Gynecological diseases

● Premature ovarian insufficiency, intrauterine adhesion, etc.






Neonatal Stem Cell Types Available for Storage


Stem cell types

Placenta amniotic mesenchymal stem cells

Placenta subtotipotent stem cells

Umbilical cord mesenchymal stem cells

Perinatal hematopoietic stem cells

Placenta blood hematopoietic stem cells

Material source

Placenta

Umbilical cord

Perinatal and postpartum appendages

Direction of differentiation

Germ cells, neural stem cells, osteoblasts, and chondrocytes

Skin, nerves, lungs, liver tissue, adipocytes, hematopoietic cells, myocytes, and osteoblasts

Multiple tissue cells, including bone, cartilage, muscle, tendon, ligament, nerve, blood vessel, epithelium, and endothelium

Erythrocytes, leukocytes, immune cells, etc.

Proliferative capability

Strong

Strong

Strong

Weak

Usage

Multiple times

Multiple times

Multiple times

Provides multi-bag storage

(1–2 times)

Scope of application


Reproductive system diseases:

Ovarian insufficiency, premature ovarian failure, prostatitis, and sexual dysfunction 


Neurological diseases:

Spinal cord injury, Parkinson's disease 

 

Degenerative diseases:

Alzheimer's disease, cerebellar atrophy

 

Respiratory diseases:

Acute lung injury/respiratory distress

Neurological diseases:

Neural tube defects, hypoxic-ischemic encephalopathy, pediatric rare diseases, etc.

 

 

Cardiovascular and cerebrovascular diseases:


Myocardial infarction, cerebral infarction, etc.

Metabolic diseases:

Diabetes, gout, etc.

 

Immune system diseases:

Rheumatoid arthritis, graft-versus-host disease

 

Bone tissue diseases:

Osteoarthritis, cartilage injury, tendon injury, etc.

 

Gastrointestinal diseases:

Liver cirrhosis, renal insufficiency, etc.

 

Combined transplantation with hematopoietic stem cells for the treatment of hematologic diseases

Hematologic diseases:

Leukaemia, aplastic anemia, severe thalassemia, etc.

 

Malignant tumors:

Lymphoma, etc.

Other effects

Activating dormant cells, improving sub-health, and regulating physiological functions

Matching requirements

No matching requirements, suitable for autologous use and family use, with better biocompatibility and enhanced efficacy.

For bone marrow transplantation, HLA matching is not required for autologous use, and the matching rate among family members can be as high as 25%–50%. For non-bone marrow stem cell sources, HLA matching is still not necessary.


1999: 

● Horwitz et al. used mesenchymal stem cells for the treatment of pediatric osteogenesis imperfecta and type I collagen deficiency in the USA


2003:

● Mazzini et al. used mesenchymal stem cells for the treatment of amyotrophic lateral sclerosis in Italy

● Fouillard et al. used mesenchymal stem cells for the treatment of aplastic anemia in France


2011: 

● Treatment with mesenchymal stem cells significantly improved the activities of daily living in 229 patients with cerebral palsy in the Chinese PLA 463 Hospital


2015:

● A nerve regeneration collagen scaffold combined with mesenchymal stem cells for spinal cord injury has entered clinical research


2002: 

● Koc et al. used mesenchymal stem cells for the treatment of mucopolysaccharidosis in the USA;

● Mesenchymal stem cells were used for the treatment of femoral head necrosis in the USA\


2005:

● Mesenchymal stem cells were used for the treatment of stroke in South Korea

● Rasulov et al. used mesenchymal stem cells for the treatment of skin burns in Russia

● Eighteen patients with aplastic anemia received mesenchymal stem cell therapy at the Twelfth People's Hospital of Guangzhou, with an overall effective rate of 72.2%







Uses of Umbilical Cord Mesenchymal Stem Cells:


Mesenchymal stem cells originate from the mesoderm during early development and are classified as pluripotent stem cells. Named for their presence in mesenchymal tissues, they exhibit multidirectional differentiation potential, support hematopoietic reconstruction, modulate immune responses, and possess self-renewal capacity. Under specific in vivo or in vitro induction conditions, mesenchymal stem cells can differentiate into various tissue-specific cell types, including osteoblasts, chondrocytes, myocytes, tenocytes, ligament cells, neurons, hepatocytes, cardiomyocytes, vascular cells, epithelial cells, endothelial cells, and adipocytes. Mesenchymal stem cells retain their multidirectional differentiation potential even after repeated subculturing and cryopreservation, making them ideal seed cells for repairing tissue and organ damage caused by aging or disease.


● Osteoarthritis

● Autism 

● Spinal cord injury

● Cerebral palsy

● Myocardial infarction

● Diabetes

● Psoriasis

● Rheumatoid arthritis 

● Retinal macular degeneration

● Liver cirrhosis

● Application scope of mesenchymal stem cells 

● Graft-versus-host disease

● Alzheimer's disease

● Infertility

● Parkinson's disease

● Aplastic anemia

● Systemic lupus erythematosus 

● Endocrine disorder